UNC Lineberger Comprehensive Cancer Center: all 424 studies
Page 5 of 5. Open to participants first (96), then studies with results posted, then the rest; newest registration first within each.
- Individualized Exercise Programs for Patients Receiving Chemotherapy for Newly Diagnosed Acute or Relapsed Myeloid Leukemia or Lymphoblastic LeukemiaCompletedNCT00499759Not applicable
- Fludeoxyglucose F 18-PET Imaging for Early Detection of Residual Disease in Patients Undergoing Radiofrequency Ablation of Liver Metastases From Colorectal CancerCompletedNCT00499395Not applicable
- Low Antioxidant Diet in Controlling Cachexia in Patients With Oropharyngeal Cancer Receiving Chemotherapy and Radiation TherapyCompletedNCT00486304Phase 1
- Visibility of Lesion Characteristics With Phase Contrast MammographyCompletedNCT00467727Not applicable
- Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney CancerCompletedNCT00405366Early Phase 1
- Lapatinib and Radiation Therapy in Treating Patients With Locally Recurrent or Chemotherapy-Refractory Locally Advanced or Metastatic Breast CancerCompletedNCT00379509Phase 1
- Bortezomib, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory Low-Grade, Follicular, or Mantle Cell Non-Hodgkin's LymphomaCompletedNCT00334438Phase 1
- Vinflunine and Erlotinib or Pemetrexed in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT00320073Phase 1
- Using Magnetic Resonance Spectroscopy With MRI to Non-invasively Determine Breast Cancer Extent of DiseaseWithdrawnNCT00312637Not applicable
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine in Treating Patients With Advanced Metastatic Solid TumorsCompletedNCT00307255Phase 1
- Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With PegfilgrastimCompletedNCT00280787Phase 2
- Biomarkers in Patients With Rectal Cancer Undergoing Chemotherapy and Radiation TherapyCompletedNCT00280761
- Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal CancerCompletedNCT00280176Phase 1
- Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract CancerCompletedNCT00266097Phase 1
- Octreotide in Treating Patients With Locally Advanced or Metastatic Liver CancerCompletedNCT00257426Phase 2
- Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast CancerCompletedNCT00237627Phase 1/2
- Molecular Marker Profiling of Axillary Lymph Nodes in Predicting Response in Patients With Locally Advanced or Metastatic Breast Cancer Who Are Undergoing Chemotherapy Followed By SurgeryCompletedNCT00233974Phase 2
- Erlotinib in Treating Patients With Progressive Glioblastoma MultiformeTerminatedNCT00227032Phase 1
- Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal WomenCompletedNCT00099008Phase 1
- Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical ProstatectomyTerminatedNCT00073970Phase 2
- Capecitabine, Paclitaxel, and Trastuzumab in Treating Patients With Metastatic Breast CancerCompletedNCT00006108Phase 1/2
- Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate CancerWithdrawnNCT00005827Phase 1
- High-Dose Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Metastatic Breast CancerCompletedNCT00003392Phase 2
- Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the EsophagusCompletedNCT00002984Phase 1/2
← UNC Lineberger Comprehensive Cancer Center overview and focus areas